Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur A. COVANIS |
Documents disponibles écrits par cet auteur (1)
Faire une suggestion Affiner la recherche
Once-daily sodium valproate in the treatment of epilepsy / A. COVANIS in Developmental Medicine & Child Neurology, 22-2 (April 1980)
[article]
Titre : Once-daily sodium valproate in the treatment of epilepsy Type de document : Texte imprimé et/ou numérique Auteurs : A. COVANIS, Auteur ; P. M. JEAVONS, Auteur Année de publication : 1980 Article en page(s) : p.202-204 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : Using monotherapy with enteric-coated sodium valproate, seizures have been completely controlled in 35 patients with administration of the drug once daily, usually at night. The mean serum levels in seven patients were the same whether the drug was taken once or twice daily. The mean serum level was 65.4 mg/l on a mean daily dose of 19.4 mg/kg. Drowsiness in the morning occurred in four patients, but only one had to return to twice-daily administration. Compliance improves with once-daily administration. Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=505
in Developmental Medicine & Child Neurology > 22-2 (April 1980) . - p.202-204[article] Once-daily sodium valproate in the treatment of epilepsy [Texte imprimé et/ou numérique] / A. COVANIS, Auteur ; P. M. JEAVONS, Auteur . - 1980 . - p.202-204.
Langues : Anglais (eng)
in Developmental Medicine & Child Neurology > 22-2 (April 1980) . - p.202-204
Index. décimale : PER Périodiques Résumé : Using monotherapy with enteric-coated sodium valproate, seizures have been completely controlled in 35 patients with administration of the drug once daily, usually at night. The mean serum levels in seven patients were the same whether the drug was taken once or twice daily. The mean serum level was 65.4 mg/l on a mean daily dose of 19.4 mg/kg. Drowsiness in the morning occurred in four patients, but only one had to return to twice-daily administration. Compliance improves with once-daily administration. Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=505